What is MYELOMA?
¡ Multiple myeloma, also called simply “myeloma,” is a cancer of the bone marrow plasma cells. Myeloma is called “multiple” because there are frequently multiple areas in the bone marrow where it grows. Myeloma cells are cancerous plasma cells.
¡ Myeloma is treatable and many patients live long and productive lives after being diagnosed.
¡ The National Cancer Institute SEER Program estimates that 36,110 new cases of myeloma were diagnosed in the U.S. in 2025.
¡ In 70% of patients, the most common symptoms of myeloma are back or bone pain, unexplained fatigue, and recurrent or persistent infections.
¡ Men are more likely than women to develop myeloma. It is most frequently diagnosed in individuals who are 65–74 years old, but it is now also being diagnosed in people younger than 50.
¡ Myeloma is the most common blood cancer in patients of African descent, who have twice the risk of developing myeloma when compared to White patients. Visit mpower.myeloma.org.
The International Myeloma Foundation is here to help. You are not alone.
Our Mission
To improve the quality of life of myeloma patients while working toward prevention and a cure
Our Vision
A world where every myeloma patient can live life to the fullest, unburdened by the disease
What is the IMF?
Founded in 1990, the International Myeloma Foundation (IMF) is the world’s leading organization dedicated to multiple myeloma.
The IMF is steadfast in its mission: improving the quality of life of myeloma patients while working toward prevention and a cure. The IMF serves people affected by myeloma at every stage of the disease.
The IMF combines world-class research, trusted education, global advocacy, and direct support.
The IMF International Myeloma Working Group® (IMWG®) is a cornerstone of this work. The IMWG is comprised of more than 350 renowned researchers and clinicians who establish the guidelines that shape how myeloma is diagnosed, treated, and managed worldwide.
The IMF ensures that scientific advances translate into better patient care and outcomes.
Through the IMF InfoLine, educational programs, a global network of support groups, the 24/7 generative-AI myeloma assistant Myelo®, and our advocacy for healthcare access, the IMF helps people living with myeloma and their care partners navigate diagnosis and survivorship.
Follow the IMF on:
IMFMyeloma /myeloma @imfmyeloma
@imfmyeloma
international myeloma foundation imfmyeloma.bsky.social
myeloma.org